Payden Equity Income Fund Adviser Cl (PYVAX) NASDAQ

17.78

+0.09(+0.51%)

Updated at December 04 08:07AM

Currency In USD

Valuation

Market CapN/A
Enterprise ValueN/A
P/E Ratio0
PEG Ratio0
Price/Sales Ratio137.27
Price/Book Ratio0
Enterprise/Revenue137.27
Enterprise/EBITDA11.54

Fiscal Year

Fiscal YearSeptember 30, 2023
Most Recent QuarterSeptember 30, 2023

Profitability

Profit Margin12.14
Operating Margin0.24

Management Effectiveness

Return On Assets0.17
Return On Equity0.18

Income Statement

Revenue9.2M
Revenue/Share0
Gross Profit9.2M
EBITDA109.44M
Net Income111.63M
Diluted EPS2.77

Balance Sheet

Total Cash0
Total Cash/Share0
Total Debt0
Total Debt/Equity0
Current Ratio0.73
Book Value Per Share0

Price History

52-Week Change-10.25
52-Week High19.79
52-Week Low14.32
Moving Average 50 Days17.48
Moving Average 200 Days16.62

Statistics

Average Volume0
Shares Outstanding71.01M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.16
Trailing Annual Dividend Yield0.91
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A